Pharmaceutical wholesalers are poised to grow their physician management businesses as private equity investment slows.
Backing from companies like McKesson, Cencora and Cardinal Health can help physician groups weather drug shortages and inflation, among other clinical and financial hurdles, some doctors said. Wholesalers are filling a void left by private equity firms that have retreated due to economic headwinds and rising regulatory scrutiny, advisers said.
Read the full article at Modern Healthcare.